NASDAQ:XRTX Stock Quote
0.9700
+0.0100 (1.04%)
Xortx Therapeutics Inc is a biotechnology company dedicated to developing innovative therapies for kidney-related conditions, particularly focused on diseases such as chronic kidney disease and metabolic disorders
The company aims to address significant unmet medical needs by advancing its proprietary drug candidates through clinical trials and bringing novel solutions to patients suffering from these challenging health issues. By leveraging advancements in science and technology, Xortx is committed to improving the quality of life for individuals impacted by kidney diseases.